Antigen Archives - tgiHealthCareerp

What Missouri learned the hard way about rapid covid testing in schools

08/26/2021 Antigen, children, health care

Early in the tumultuous 2020-21 school year, Missouri officials made a big gamble: set aside roughly 1 million rapid covid

Health News

SARS-CoV-2 oral vaccine booster shows promise in animal tests

06/16/2021 3D Imaging, Antigen, coronavir

The devastating medical and economic impacts of the coronavirus disease 2019 (COVID-19) pandemic have triggered an unprecedented global effort toward

Health News

Gauging the efficacy and ease of use of at-home COVID-19 tests

06/03/2021 Antigen, efficacy, research

As the country gets vaccinated and begins to re-open, testing remains a key element of safe interactions. Rapid testing for

Health News

Candidate coronavirus vaccines show promising results in early animal testing

04/18/2021 Antigen, Bacteria, coronavirus, diarrhea, DNA, e-coli, Genes, genome, Genomic, Immune Response, immune system, immunology, laboratory, Manufacturing, Medicine, pandemic, Plasmid, research, SARS, SARS-CoV-2, vaccine, Veterinary, virus

A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early

Health News

L452R and Y453F SARS-CoV-2 mutations increase transmission and evade immunity

04/12/2021 ACE2, Antigen, binding affinity, blood, coronavirus, Coronavirus Disease COVID-19, Human Leukocyte Antigen, Immune Response, Leukocyte, Mutation, protein, Protein Stability, Public Health, Receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome

Mutations from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have created multiple variants. Some variants, such as those found

Health News

New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

04/06/2021 ACE2, Angiotensin, antibodies, antibody, Antigen, Cell, coronavirus, Coronavirus Disease COVID-19, Glycine, Glycoprotein, Heparin, Immune Response, immunization, Nanoparticle, Nanoparticles, protein, Receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome, vaccine, virus

In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift

Health News

Study may help develop effective biosensors for non-invasive diagnosis of prostate cancer

03/23/2021 Antigen, Biosensor, cancer, Education, efficacy, Ethanol, gene, Prostate, Prostate Cancer, research, Sulfur

The efficacy of biosensors used in clinical tests depends critically on the surface of the device on which the biorecognition

Health News

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

03/09/2021 Antigen, Cell, Chromatography, coronavirus, Coronavirus Disease COVID-19, efficacy, healthcare, Helicobacter pylori, Nanoparticle, Nanoparticles, pandemic, protein, Receptor, respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, vaccine, virus, Weight Loss

COVID-19 (coronavirus disease 2019) is caused by a new positive-strand RNA coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),